Experience
Payapps to Be Acquired by Autodesk
January 26, 2024
Cooley advised cloud-based construction software company Payapps and its private equity sponsor IFM Investors on a definitive agreement in which Payapps will be acquired by Autodesk, a multinational software company.
Related contacts
Related Practices & Industries
Yieldstreet Completes Acquisition of Cadre
January 23, 2024
Cooley advised Yieldstreet, a leading private market investing platform, on its acquisition of Cadre, an online real estate-focused investment platform that serves institutional and high net worth investors.
Related contacts
Related Practices & Industries
Allorion Therapeutics Announces Exclusive Option, Global License Agreement With AstraZeneca
January 2, 2024
Cooley advised Allorion Therapeutics, a US- and China-based biotechnology company that focuses on the discovery of new small molecule drugs for treating cancer and autoimmune diseases, on its exclusive option and global license agreement with AstraZeneca to develop and commercialize a novel epidermal growth factor receptor (EGFR) L858R mutated allosteric inhibitor as a potential new treatment for advanced EGFR-mutant non-small-cell lung cancer.
Related contacts
Related Practices & Industries
HealthTrio Combines With mPulse and Decision Point Healthcare Solutions
December 19, 2023
Cooley advised HealthTrio, a top provider of comprehensive health management and member engagement solutions, on its strategic acquisition by mPulse, which also announced its acquisition of Decision Point Healthcare Solutions.
Related contacts
Related Practices & Industries
Propella Therapeutics Enters Merger Agreement With Astellas Pharma
November 16, 2023
Cooley advised Propella Therapeutics, a privately held biopharmaceutical company that has leveraged a wholly owned proprietary platform that combines medicinal chemistry with lymphatic targeting to create new oncology drugs, on its merger agreement with Astellas Pharma in which Astellas will acquire Propella through a US subsidiary.